Quick Enquire
Camostat Mesylate API manufacturers

Camostat Mesylate API manufacturers

Camostat Mesylate as an inhibitor is utilized at the beginning of the treatment of chronic pancreatitis. It falls under the category of an anticoagulant. A.R. Life Sciences are a prominent Camostat Mesylate API manufacturers. We develop an effective range of APIs. All the APIs we manufacture are developed following GMP standard formulations. We serve clients all over India and overseas due to our GMP standard formulations. A.R. Life Sciences was established in 2007, we are an ISO 9001:2015 certified company with our units being GMP certified. One of our units is being approved by USFDA.
Our dedicated Research development team strives constantly to synthesize products at competitive prices by improving the production process. We drive by the goal to provide high- quality products to our clients consistently. As Camostat Mesylate API manufacturers. We follow stringent GMP rules. All our products are available in powdered format. We deliver orders that start from 100 gms in quantity.

Camostat Mesylate is the mesylate salt form of camostat, an orally bioavailable, synthetic serine protease inhibitor, with anti-inflammatory, antifibrotic, and potential antiviral activities. camostat may inhibit the activity of transmembrane protease, serine 2 (TMPRSS2), a host cell serine protease that mediates viral cell entry for influenza virus and coronavirus, thereby inhibiting viral infection and replication.

16060-65-4:

Camostat Mesylate

42823-46-1:

Camostat Mesylate

59721-16-3:

Camostat Mesylate
  • Product Features
  • Advantages
  • Applications
  • Specifications
  • Form: Powder
  • Minimum order quantity: 100gram
  • Categories: Pharma intermediates, Pharma API, Pharmaceutical intermediates, Pharmaceutical API, Active Pharmaceutical Ingredients
  • Usage/Application: Commercial
  • Manufacturer: A. R. Life sciences Pvt Ltd.
  • Cancer (Bendamustine intermediates, Imatinib intermediates)
  • Cardiovascular (Clopidogrel bisulphate intermediate & API)
  • Anti-Coagulant (Dabigatran intermediates & API, CamostatMesylate intermediates & API)
  • Leukemia (Dasatinib intermediates)
  • Pain (Elagolix intermediate)
  • Gaucher disease (Eliglustat intermediates)
  • Osteoporosis (Ibandronate intermediate)
  • Cystic fibrosis (Ivacaftor intermediates)
  • Hyperuricemia (Lesinurad intermediate)
  • Urinary Incontinence (Mirabegron, Solifenacin intermediates)
  • Nausea & vomiting (Ondansetron intermediates)
  • Anti-Psychotic (Paliperidone/Risperidone, Quetiapine intermediates)
  • Acute Diarrhoea (Racecadotril intermediates)
  • Deep vein thrombosis (Rivaroxaban intermediate)
  • Type 2 Diabetes (Sitagliptin intermediates)
  • NSAID (Etodolac API)
  • Antibiotic (Sparfloxacin API)
  • Anti-Arrhythmic agent (Adenosine API)
  • Anti-Lipemic (Rosuvastatin calcium API)
  • Iron chelator (Deferasirox)
  • Purity, Grade

Camostat Mesylate intermediates Specifications :

Intermediate CAS No API/End Use Status Purity
4-Guanidinobenzoic Acid 16060-65-4 Camostat mesylate Under development 99.46%
4- Guanidinobenzoic Acid HCl 42823-46-1 Camostat mesylate Under development 99.51%
4-Hydroxy Benzeneacetic Acid2-(Dimethylamino)-2-oxoethyl Ester 59721-16-3 Camostat mesylate Under development 99.29%

Camostat Mesylate intermediates Product Details :

Minimum Order Quantity 100 Gram
Cas No 59721-16-3,16060-65-4,42823-46-1
Usage/Application Commerical
Packaging Size Standard HDPE drums
Manufacturer AR Life Sciences Pvt Ltd.
Form Powder